CytomX Therapeutics appoints Dr Chip Scarlett to the Board of Directors
– USA, CA – CytomX Therapeutics (Nasdaq:CTMX), a biopharmaceutical company developing investigational Probody therapeutics for the treatment of cancer, today announced that John “Chip” A.…